Tech Company Inital Public Offerings
BioPharmX IPO
Headquartered in San Jose, BioPharmX is now a public company.
Transaction Overview
Company Name
Announced On
6/25/2015
Transaction Type
IPO
Amount
$9,900,000
Proceeds Purpose
As of April 30, 2015, we had cash of $0.5 million. We currently intend to use the net proceeds we receive from this offering and the KIP private placement, together with our existing cash, as follows: approximately $4.0 million for research and development expenses associated with the development of our product candidates and research and development pipeline; approximately $3.0 million for marketing and advertising expense to build awareness and sell through volume at drug stores and supplement stores for VI2OLET; and the balance to be used primarily to fund working capital, capital expenditures and other general corporate purposes, including strategic hires.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
115 Nicholson Ln.
San Jose, CA 95134
USA
San Jose, CA 95134
USA
Phone
Website
Email Address
Overview
BioPharmX, Inc. provides innovative drug-delivery products through its patented platform technologies for pharmaceutical and OTC applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Tierney
Chief Financial Officer
Joyce Goto
Chief Medical Officer
Scott Herron
Chief Operating Officer
Steven Bosacki
Browse more venture capital transactions:
Prev: 6/25/2015: STAND venture capital transaction
Next: 6/25/2015: Guavus venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs